The Latest

UN Must Face the Facts: IP Protections are Not a Barrier to Fighting TB

Some well-funded activists are singling out intellectual property protections as the culprit for poor access to Tuberculosis medicines, even as developing and middle-income countries lack sufficient infrastructure and financing to treat and cure the disease. Read why September’s UN High Level Meeting on TB must address the real barriers to access, not attack innovation.

Use the dropdown to filter articles by tags.